comScore
Active Stocks
Fri Sep 29 2023 15:59:14
  1. Tata Steel share price
  2. 129 1.78%
  1. NTPC share price
  2. 245.65 3.3%
  1. Power Grid Corporation Of India share price
  2. 199.85 -0.45%
  1. State Bank Of India share price
  2. 598.7 1.48%
  1. Wipro share price
  2. 406.25 0.11%
Business News/ News / India/  Hetero launches covid-19 drug under brand Favivir at 59 per tablet
Back

Hetero launches covid-19 drug under brand Favivir at ₹59 per tablet

Favipiravir is used in the treatment of mild-to-moderate covid-19, and constitutes 122 pills for over a period of two weeks
  • With that dosage, Hetero’s Favivir will cost ₹7,198 for the entire course
  • The AIDS and TB medicines would join a list of nearly 400 essential drugs under price control in India. Photo: Ramesh Pathania/MintPremium
    The AIDS and TB medicines would join a list of nearly 400 essential drugs under price control in India. Photo: Ramesh Pathania/Mint

    NEW DELHI: Hetero Healthcare Ltd on Wednesday launched the generic covid-19 drug favipiravir in India under the brand name Favivir at 59 per pill. The product is cheaper than those of earlier entrants Glenmark Pharmaceuticals Ltd and Cipla Ltd.

    The product is available at all retail and hospital pharmacies across the country starting today and will be sold only on prescription, the company said.

    The Hyderabad-based pharmaceutical company has been granted manufacturing and marketing approval for the anti-viral medicine by the Drug Controller General of India (DCGI) V.G. Somani, it said in a statement.

    Favipiravir is used in the treatment of mild-to-moderate covid-19, and constitutes 122 pills over a period of two weeks, as per the clinical management protocol for the medicine allowed by the regulator. With that dosage, Hetero’s Favivir will cost 7,198 for the entire course.

    Hetero’s Favivir is the second drug developed by Hetero for the treatment of Covid-19. Last month, the firm had launched Covifor, a licensed generic of Gilead Sciences Inc’s novel drug Remdesivir, for the treatment of severe covid-19 patients.

    The drug will be being manufactured at its formulation facility in Hyderabad, which has been approved by stringent global regulatory authorities such as US FDA and the EU, among others.

    "Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!

    Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
    More Less
    Updated: 29 Jul 2020, 03:03 PM IST
    Next Story
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App